tenofovir disoproxil
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AF - Nucleoside And Nucleotide Reverse Transcriptase Inhibitors -> J05AF07 - Tenofovir Disoproxil
Administration category:
Free
Medicine group:
antiviral
Brand name:
Viread
Standard dosages
| Weight | ROA | Load | Dosage |
|---|---|---|---|
|
ROA: po |
Load: - |
Dosage: 245mg 1 dd |
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: po | ||||
|
GFR: 30 - 50 |
Interval: 48 Hours |
|||
|
GFR: 10 - 30 |
Comments: elke 3-4 dagen |
|||
|
GFR: <10 |
Dosage: do not prescribe |
|||
Renal elimination:
70-80%
Dosage:
dependent on kidney function
Renal function-replacement therapy
CAPD: gebruik vermijden
Hemo dialysis: dialized - 16,5 mg na elke dialysesessie, onder controle van de tenofovirspiegel
CAV / VVHD: 33 mg 1x per dag, onder controle van de tenofovirspiegel
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-2041.3
Updated: 01/24/2020 - 13:05
Status: Published